Related Experiment Video

Updated: Jul 19, 2026

A Novel Strategy Combining Array-CGH, Whole-exome Sequencing and In Utero Electroporation in Rodents to Identify Causative Genes for Brain Malformations
08:22

A Novel Strategy Combining Array-CGH, Whole-exome Sequencing and In Utero Electroporation in Rodents to Identify Causative Genes for Brain Malformations

Published on: December 1, 2017

Phenylketonuria in pediatric neurology practice: a series of 146 cases

Kalbiye Yalaz1, Lale Vanli, Engin Yilmaz

  • 1Hacettepe University, Ankara, Turkey.

Journal of Child Neurology
|November 10, 2006
PubMed

Insights

Phenylketonuria (PKU) treatment age impacts neurologic outcomes. Early dietary intervention for PKU is crucial for managing developmental delays and improving cognitive function in affected individuals.

Area of Science:

  • Neurology
  • Metabolic Disorders
  • Genetics

Background:

  • Phenylketonuria (PKU) is a rare genetic disorder.
  • Neurologic manifestations in PKU are often linked to phenylalanine buildup.
  • Early diagnosis and treatment are critical for preventing severe intellectual disability.

Purpose of the Study:

  • To analyze the neurologic outcomes of phenylketonuria patients treated at various ages.
  • To investigate the influence of treatment timing on neurologic development.
  • To explore factors contributing to divergent outcomes in siblings with PKU.

Main Methods:

  • Retrospective analysis of 146 phenylketonuria cases.
  • Inclusion of 9 sibling pairs with varying treatment histories.
  • Clinical assessment of neurologic manifestations, including cognitive and motor function.

Main Results:

  • Motor retardation was common and improved with dietary treatment.
  • Hypotonia and diminished reflexes were more prevalent than hypertonia.
  • Four sibling pairs exhibited divergent neurologic outcomes, with later-treated siblings showing higher function.

Conclusions:

  • Treatment timing significantly influences neurologic manifestations in phenylketonuria.
  • Individual variability in phenylalanine transport or other factors may explain divergent sibling outcomes.
  • Prompt dietary management is essential for optimizing neurologic development in PKU patients.

More Related Videos

Concurrent Collection of Fetal Murine Brain and Serum to Assess Effects of Maternal Diet on Nutrition and Neurodevelopment in Neurofibromatosis Type 105:44

Concurrent Collection of Fetal Murine Brain and Serum to Assess Effects of Maternal Diet on Nutrition and Neurodevelopment in Neurofibromatosis Type 1

Published on: May 17, 2024

Related Concept Videos

Inborn Errors of Metabolism01:20

Inborn Errors of Metabolism

Phenylketonuria (PKU) is a protein metabolism disorder characterized by high blood levels of the amino acid phenylalanine. This results from a mutation in the gene responsible for phenylalanine hydroxylase, an enzyme that converts phenylalanine into tyrosine. When this enzyme is deficient, phenylalanine builds up in the blood, leading to symptoms such as vomiting, rashes, seizures, growth deficiency, and severe mental retardation. An early diagnosis and a diet restricting phenylalanine intake...
Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses a challenge in...
Overview of Protein Metabolism01:21

Overview of Protein Metabolism

Proteins are broken down into amino acids during digestion. Unlike fats and carbohydrates, which are stored for later use, proteins are not. Instead, amino acids are either used to produce ATP through oxidation or contribute to the creation of new proteins for the growth and repair of the body. Any surplus amino acids from the diet are converted into glucose or triglycerides rather than excreted.
Amino acids play various roles in the body once they are absorbed into cells. They are restructured...
Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

Pharmacokinetics in Pediatric Patients: Drug Distribution

Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight, compared...